For the quarter ending 2025-09-30, KTTA has $13,630,664 in assets. $1,423,982 in debts. $4,122,953 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,122,953 | 7,217,052 | ||
| Restricted cash | 100,599 | - | ||
| Prepaid expenses | 1,286,009 | 1,301,705 | ||
| Other current assets | 19,665 | 117,842 | ||
| Property and equipment, net | - | 113,564 | ||
| Total current assets | 5,529,226 | 8,636,599 | ||
| Intangibles, net | 6,838,527 | 6,996,068 | ||
| Goodwill | 1,262,911 | 1,262,911 | ||
| Total assets | 13,630,664 | 17,009,142 | ||
| Accounts payable and accrued liabilities | 1,337,801 | 1,581,501 | ||
| Financed director and officer insurance premiums | 39,310 | 155,455 | ||
| Total current liabilities | 1,377,111 | 1,736,956 | ||
| Warrant liabilities | 46,871 | 93,741 | ||
| Total non-current liabilities | 46,871 | 93,741 | ||
| Total liabilities | 1,423,982 | 1,830,697 | ||
| Common stock, par value 0.0001 per share, 100,000,000 shares authorized 7,443,577 shares and 1,394,263 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 743 | 743 | ||
| Additional paid-in capital | 72,087,231 | 72,034,244 | ||
| Accumulated other comprehensive loss | 18,301 | 5,631 | ||
| Accumulated deficit | -59,899,593 | -56,862,173 | ||
| Total stockholders equity | 12,206,682 | 15,178,445 | ||
| Total liabilities and stockholders equity | 13,630,664 | 17,009,142 | ||
Pasithea Therapeutics Corp. (KTTA)
Pasithea Therapeutics Corp. (KTTA)